Investor Relations
Welcome to Alzinova AB’s IR pages.
Alzinova AB is a company specializing in the treatment of Alzheimer’s disease – one of our major health scourges, without effective treatment options.
Latest press releases
- 2021-02-25 | Regulatory Alzinova AB Year-end Report 2020
- 2021-01-08 | Regulatory Drug substance for the ALZ-101 vaccine is now produced – meets the requirements of the upcoming clinical Phase 1b study